Academic degree

MBBS, PhD

Research interest
My research interests focus on understanding and managing infectious diseases through key areas including antimicrobial resistance, pathogenesis, diagnostic microbiology, infection control, vaccine development, global health, the One Health approach, genomics, microbial ecology, and translational research. I investigate resistance mechanisms, host-pathogen interactions, rapid diagnostics, and novel therapeutics, while also emphasizing surveillance, prevention strategies, and the development of effective vaccines. Additionally, I study emerging pathogens, zoonotic infections, and the impact of the environment on disease spread. My goal is to advance infectious disease knowledge, improve diagnostic and therapeutic strategies, and develop effective prevention measures to enhance global public health.

Publications
1. Hudu, S. A., Jimoh, A. O., Adeshina, K. A., Otalike, E. G., Tahir, A., & Hegazy, A. A. (2024). An Insight into the Success, Challenges, and Future Perspectives of Eliminating Neglected Tropical Diseases. Scientific African, e02165. 2. Hudu, Shuaibu Abdullahi, Shinkafi, Sa’adatu Haruna and Jimoh, Abdulgafar Olayiwola. ( 2024) "A critical review of diagnostic and prognostic markers of chronic hepatitis B infection" Medical Review. https://doi.org/10.1515/mr-2024-0022 3. Abubakar, M.B., Yusuf, A.P., Usman, D., Abubakar, I.B., Katsayal, B.S., Sadiq, I.Z., Hassan, S.M., Forcados, G.E., Ibrahim, K.G., Hudu, S.A. and Muhammad, A. (2024). Potential benefits and challenges on the use of phytochemicals for obese COVID-19 patients: A review. Phytomedicine Plus, 100526. 4. Hudu, S. A., Jimoh, A. O., Alqtaitat, A., & Fayig, E. (2024). The Role of Seasonal Influenza in Compounding the Outbreak of Infectious Diseases: A Critical Review. Biomedical and Pharmacology Journal, 17(1), 1-13. 5. Hudu, S. A., Jimoh, A. O., Ibrahim, K. G., Mohammed, Y., Adeshina, K. A., Jimoh, A. K., ... & Jama, A. M. (2024). Dissecting the low morbidity and mortality during the COVID-19 pandemic in Africa: a critical review of the facts and fallacies. Advances in Traditional Medicine, 1-12. 6. Hudu, S.A.; Elmigdadi, F.; Qtaitat, A.A.; Almehmadi, M.; Alsaiari, A.A.; Allahyani, M.; Aljuaid, A.; Salih, M.; Alghamdi, A.; Alrofaidi, M.A.; et al. (2023). Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. J. Clin. Med. 12, 5114. https://doi.org/10.3390/ jcm12155114 7. Hudu, S.A.; Alshrari, A.S.; Al Qtaitat, A.; Imran, M. (2023). VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions. Biomedicines, 11, 1106. https://doi.org/10.3390/ biomedicines11041106 8. Alshrari, A. S., Hudu, S. A., Elmigdadi, F., & Imran, M. (2023). The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects. Biomedicines, 11(2), 426. https://doi.org/10.3390/biomedicines1102042